We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Microfluidic Device Simplifies Cancer Screening Procedures

By LabMedica International staff writers
Posted on 05 Aug 2019
A novel microfluidic device is set to simplify screening for cervical cancer by efficiently isolating and trapping single cells for identification using direct immunostaining techniques.

Several specific tests for cervical screening are available, including p16/Ki67 dual immunostaining for direct identification of cancerous cells in the cervix. More...
Despite these advances in staining technology, manual screening of cells in an entire glass slide remains the standard clinical procedure for quantification and interpretation of immunocytochemical features of the cells.

To improve this situation, investigators at the University of Tokyo (Japan) developed a microfluidic device containing an electroactive microwell array with barriers (EMAB) for highly efficient single-cell trapping followed by on-chip immunofluorescence analysis with minimum loss of the sample.

The EMAB device utilizes patterned electrodes at the bottom of cell-sized microwells to trap single cells using dielectrophoresis (DEP) and cell-holding structures behind the microwells to stabilize the position of trapped cells even without functioning DEP.

The investigators evaluated the performance of the EMAB device for single-cell trapping by sequestering formalin-fixed HeLa cells (a human cervical cancer cell line) and for cell holding by monitoring the release of trapped cells after turning off DEP.

Results revealed that the device interacted with the fixed HeLa cells with 98% efficiency for cell-trapping and 92% efficiency for cell-holding. In addition, the investigators successfully demonstrated high-efficiency on-chip immunofluorescence analysis with minimal loss of sample.

"Major challenges were trapping suspended cells at the single-cell level and analyzing them using antibodies with minimum loss of trapped cells," said contributing author Dr. Soo Hyeon Kim, lecturer in the institute of industrial science at the University of Tokyo. "By just putting a small structure behind the microwell, the cells were efficiently stayed in the microwells even with the unstable flow used for delivery of reagents. Combining EMAB with p16/Ki67 dual immunostaining could be a useful tool to provide molecular evidence that might help pathologists make a cervical cancer diagnosis."

The EMAB device was described in the July 30, 2019, online edition of the journal Biomicrofluidics.

Related Links:
University of Tokyo


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Microscope
dIFine
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.